FDA Inspection 1022642 — CSL Plasma Inc.

CSL Plasma Inc. — FEI 1643760

The FDA completed an inspection of CSL Plasma Inc. on July 14, 2017 in Grand Prairie, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 14, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Grand Prairie, TX (United States)